The above chart presents the market trend analysis for distinct pharma from 2018 to 2019.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2019, the company has completed 513 transactions, with a transaction quantity of 10961932 and a transaction weight of 0.
distinct pharma is india Supplier,
and primarily engages in the import and export business of products such as 10 tablet,sildenafil citrate,dena.
According to the 52wmb.com global trade database, as of 2019-06-27, the company has completed 1419 international trades,
with its main trading regions covering singapore,united states,qatar etc.
The core products include HS30049099,HS30043190,HS30042099 etc,
often transported via sahar air cargo acc inbom4,port ahemdabad air acc inamd4, port sahar air cargo inbom4 etc,
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on distinct pharma is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.